HBV infection, in part through the viral protein HxB, is known to stimulate the Wnt pathway (46, 47), which may be the mode of Wnt pathway activation in HCC, which, as opposed to mutational activation (Table 1), is well sensitive to clofazimine inhibition. The gene discussed is TNC; the disease is hepatocellular carcinoma.